Imperial Tobacco Canada

BAT Group (BAT) today announces the signing of a strategic collaboration agreement with Organigram Inc., a wholly-owned subsidiary of publicly-traded Organigram Holdings Inc. (collectively Organigram), focused on research and product development activities of next generation adult cannabis products, with an initial focus on cannabidiol (CBD). This agreement augments ongoing BAT activities to expand its portfolio ‘beyond nicotine’. The collaboration reinforces BAT’s consumer-centric multi-category approach, which has seen continued momentum and growth as BAT focuses on delivering on its purpose of building A Better Tomorrow™.

Today we launch a dedicated week aimed at highlighting our goals and achievements around our enhanced Environment, Social and Governance (ESG) ambitions. Across our digital channels, we will devote the entire week to sharing our sustainability story with the outside world. In 2020, we announced our new corporate purpose to deliver A Better Tomorrow™ by reducing the health impact of our business, putting sustainability front and centre. Since March last year, we: - Launched the industry’s first ever Human Rights report. -Were the only tobacco company to be included in the Dow Jones Sustainability World Index, our 19th consecutive year in the Index series. -Were awarded an ‘A’ score for climate change by the Carbon Disclosure Project (CDP). -Were named as a Diversity Leader by the Financial Times in our inaugural Diversity Leaders report.